Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Covington
McKinsey
Merck
Boehringer Ingelheim
Healthtrust
Federal Trade Commission
Baxter
Medtronic
Daiichi Sankyo

Generated: August 24, 2017

DrugPatentWatch Database Preview

CONRAY Drug Profile

« Back to Dashboard

What is the patent landscape for Conray, and what generic Conray alternatives are available?

Conray is a drug marketed by Liebel-flarsheim and Mallinckrodt and is included in four NDAs.

The generic ingredient in CONRAY is iothalamate sodium. There is one drug master file entry for this compound. Additional details are available on the iothalamate sodium profile page.

Summary for Tradename: CONRAY

Patents:0
Applicants:2
NDAs:4
Suppliers / Packagers: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CONRAY at DailyMed

Pharmacology for Tradename: CONRAY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheim
CONRAY
iothalamate meglumine
INJECTABLE;INJECTION013295-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Mallinckrodt
CONRAY 400
iothalamate sodium
INJECTABLE;INJECTION014295-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
CONRAY 30
iothalamate meglumine
INJECTABLE;INJECTION016983-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Mallinckrodt
CONRAY 325
iothalamate sodium
INJECTABLE;INJECTION017685-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
CONRAY 43
iothalamate meglumine
INJECTABLE;INJECTION013295-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Cipla
Teva
Novartis
Covington
Julphar
Farmers Insurance
McKesson
Boehringer Ingelheim
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot